Cancer

Reimagining diagnostics: Why AI is essential for the future of NHS pathology

AI-powered pathology presents the NHS with a unique opportunity to enhance cancer detection. Paige AI explains how its tools can facilitate quicker diagnostics and improve cost efficiency within the UK’s health system.

Acute myeloid leukaemia (AML) and cytarabine pharmacogenomics

Professor Jatinder Lamba from the Department of Pharmacotherapy and Translational Research gives an in-depth perspective on acute myeloid leukaemia (AML) and cytarabine pharmacogenomics Acute myeloid...

Acute myeloid leukaemia (AML)

Acute myeloid leukaemia (AML), a form of blood cancer is placed into the spotlight by Open Access Government Acute myeloid leukaemia (AML) is a form...

Technology interventions to address dyspnoea: Point-of-care lung ultrasonography

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group highlights technology interventions that address dyspnoea – focussing on point-of-care lung ultrasonography The Murray and Nadel’s...

The global burden of cancer in young adults

Dr Miranda Fidler from the International Agency for Research on Cancer highlights the burden of cancer and the need for prevention, diagnosis, and care Cancer...

Now is the time to finally prioritise lung cancer

CEO of Roy Castle Lung Cancer Foundation, Paula Chadwick, explains why it is now the time to finally prioritise lung health The events of Tuesday...

The challenge of sustainability in cancer care

All.Can shares their profound insights into the challenges concerning the need to improve the efficiency of cancer care, focusing on better outcomes for patients Healthcare...

Lymphoma – what’s that?

Experts from the Lymphoma Association offer their thoughts on the extent of lymphoma in the UK today and how treatment and diagnosis can improve Every...

The provision of effective cross-border healthcare

Professor Ruth Ladenstein from SIOPE (the European Society for Paediatric Oncology) discusses how ERN PaedCan facilitates effective cross-border healthcare The European Commission launched 24 different...

The future of the Danish Ministry of Health

Jonathan Miles from Open Access Government explored the work the Danish Ministry of Health does to improve health policy across the country The Danish Ministry...

Living with Leukaemia

Bethany Torr, campaigns and advocacy officer at Leukaemia Care introduces ‘Leukaemia’ and its different forms and explains how people live with the disease Leukaemia’ is...

Fostering and supporting excellence in clinical pharmacy practice

Islam Elkonaissi and Zahra Laftah from the UKCPA explore the British model of supporting excellence in clinical pharmacy practice In the UK, evidence that pharmacists...

Early stage diagnosis – spotting early stage cancer events

Cecilia Van Cauwenberghe, Vandana Iyer and Bhargav Rajan from Frost & Sullivan examine of how nanotechnology helps spot early stage cancer

Dose-finding trials: why not to use algorithmic designs

Prof Thomas Jaki from the Medical and Pharmaceutical Statistics Research Unit at Lancaster University sheds light on dose-finding trials

Publishing national chemotherapy data

Publishing national chemotherapy data has helped NHS hospitals make changes that should improve treatment, as Emma Saxon reveals in this article

Tumour-host interactions, paediatric sarcomas, and cancer progression

Ivan Stamenkovic, professor of experimental pathology at the University of Lausanne underlines research taking place around cancer progression Cancer progression, meaning the evolution of localised...

Developing IOT in healthcare

Jon Lee-Davey, IoT Health Lead at Vodafone, and Bernard Vrijens, from the University of Liege explain how IoT in healthcare can revolutionise hospitals

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders